Analysen von Jami Rubin
| 30.10.18 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 28.08.18 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 01.08.18 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 25.07.18 | Eli Lilly Neutral | Goldman Sachs Group Inc. | |
| 31.01.18 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 30.01.18 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 01.11.17 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 18.01.17 | Pfizer Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 13.06.16 | Johnson Johnson Neutral | Goldman Sachs Group Inc. | |
| 09.05.16 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 19.04.16 | Pfizer Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.12 | Eli Lilly neutral | Goldman Sachs Group Inc. | |
| 31.07.12 | Merck neutral | Goldman Sachs Group Inc. | |
| 17.05.11 | Merck neutral | Goldman Sachs Group Inc. | |
| 27.01.11 | Johnson Johnson neutral | Goldman Sachs Group Inc. | |
| 30.06.10 | Johnson Johnson halten | Goldman Sachs Group Inc. | |